Immunity Pharma
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jerusalem, Jerusalem, IsraelWebsite
www.immunitypharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Immunity Pharma
Immunity Pharma is a clinical-stage biopharmaceutical company focused on developing innovative compounds that enhance therapeutic cell-signaling processes for the treatment of neurodegenerative diseases, with an initial emphasis on ALS (Lou Gehrig's disease). The company is dedicated to advancing its pipeline through clinical trials, including recent positive results from a phase-2a trial of its product IPL344. Their mission is to provide effective treatments that can slow disease progression and improve patient outcomes. Immunity Pharma aims to serve patients suffering from neurodegenerative conditions, particularly those affected by ALS.Explore more
Popular SearchesImmunity Pharma LtdImmunity PharmaSIC Code 28,283NAICS Code 32,325Show moreImmunity Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunity Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Immunity Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Immunity Pharma has new funding data
Product Launch: Get notified when Immunity Pharma launches new products
Earning: See what the market has to say on Immunity Pharma recently announced quarterly report
Check if Immunity Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Immunity Pharma
Check out if Immunity Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Immunity Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Immunity Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immunity Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immunity Pharma.
Immunity Pharma Tech Stack
A closer look at the technologies used by Immunity Pharma
Immunity Pharma News & Media
Immunity Pharma Announces Positive Top Line Results from Phase 2a Trial with IPL344 in ALS Patients
Treatment with IPL344 was well tolerated Changes in the slope of decline in ALSFRS-R demonstrated 48% slower disease progression (p=0.028); and 64% slower progression when adjusted for disease stage and rate (p=0.034) Study suggests benefits in weight gain, respiration, and survival...Immunity Pharma Announces Promising Interim Results of its Phase 1/2a Study with IPL344 in ALS
Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, announced today interim results from its Phase 1/2a clinical study with IPL344, an Akt activating disease-modifying drug for the treatment of ALS. In this early stage clinical trial, disease progression rate during IPL344 treatment was about 50% slower than expected without treatment, in both functional and respiratory endpoints (ALSFRS-R and SVC, respectively). The drug also demonstrated a very favorable safety and t
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunity Pharma
Sign Up For FreeTo access detailed company insights
Immunity Pharma is a clinical-stage biopharmaceutical company focused on developing innovative compounds that enhance therapeutic cell-signaling processes for the treatment of neurodegenerative diseases, with an initial emphasis on ALS (Lou Gehrig's disease). The company is dedicated to advancing its pipeline through clinical trials, including rece... Read More
